PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy.\', \'VisMederi srl, Strada del Petriccio e Belriguardo 35, 53100 Siena, Italy.\', \'VisMederi Research srl, Strada del Petriccio e Belriguardo 35, 53100 Siena, Italy.\', \'Humanitas Gavazzeni, Via Mauro Gavazzeni 21, 24125 Bergamo, Italy.\', \'Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 134710.3390/v13071347
?:doi
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 34372553
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
?:title
  • Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34372553>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34372553>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all